138 related articles for article (PubMed ID: 8478254)
1. Terpestacin, a new syncytium formation inhibitor from Arthrinium sp.
Oka M; Iimura S; Tenmyo O; Sawada Y; Sugawara M; Ohkusa N; Yamamoto H; Kawano K; Hu SL; Fukagawa Y
J Antibiot (Tokyo); 1993 Mar; 46(3):367-73. PubMed ID: 8478254
[TBL] [Abstract][Full Text] [Related]
2. The first total synthesis of natural (+)-terpestacin, syncytium formation inhibitor.
Tatsuta K; Masuda N
J Antibiot (Tokyo); 1998 Jun; 51(6):602-6. PubMed ID: 9711228
[No Abstract] [Full Text] [Related]
3. The structure of cyclooctatin, a new inhibitor of lysophospholipase.
Aoyama T; Naganawa H; Muraoka Y; Aoyagi T; Takeuchi T
J Antibiot (Tokyo); 1992 Oct; 45(10):1703-4. PubMed ID: 1474002
[No Abstract] [Full Text] [Related]
4. Phytotoxic sesterterpene, 11-epiterpestacin, from Bipolaris sorokiniana NSDR-011.
Nihashi Y; Lim CH; Tanaka C; Miyagawa H; Ueno T
Biosci Biotechnol Biochem; 2002 Mar; 66(3):685-8. PubMed ID: 12005073
[TBL] [Abstract][Full Text] [Related]
5. The cytosporones, new octaketide antibiotics isolated from an endophytic fungus.
Brady SF; Wagenaar MM; Singh MP; Janso JE; Clardy J
Org Lett; 2000 Dec; 2(25):4043-6. PubMed ID: 11112639
[TBL] [Abstract][Full Text] [Related]
6. Anti-angiogenic activity of terpestacin, a bicyclo sesterterpene from Embellisia chlamydospora.
Jung HJ; Lee HB; Kim CJ; Rho JR; Shin J; Kwon HJ
J Antibiot (Tokyo); 2003 May; 56(5):492-6. PubMed ID: 12870816
[No Abstract] [Full Text] [Related]
7. The squalestatins, novel inhibitors of squalene synthase produced by a species of Phoma. V. Minor metabolites.
Blows WM; Foster G; Lane SJ; Noble D; Piercey JE; Sidebottom PJ; Webb G
J Antibiot (Tokyo); 1994 Jul; 47(7):740-54. PubMed ID: 8071119
[TBL] [Abstract][Full Text] [Related]
8. Darlucins A and B, new isocyanide antibiotics from Sphaerellopsis filum (Darluca filum).
Zapf S; Hossfeld M; Anke H; Velten R; Steglich W
J Antibiot (Tokyo); 1995 Jan; 48(1):36-41. PubMed ID: 7868387
[TBL] [Abstract][Full Text] [Related]
9. Deuteromycols A and B, two benzofuranoids from a Red Sea marine-derived Deuteromycete sp.
Nawwar M; Hussein S; Ayoub NA; Hashim A; Mernitz G; Cuypers B; Linscheid M; Lindequist U
Arch Pharm Res; 2010 Nov; 33(11):1729-33. PubMed ID: 21116774
[TBL] [Abstract][Full Text] [Related]
10. Nosporins A and B, new metabolites from a filamentous fungus, VKM-3750.
Kozlovsky AG; Zhelifonova VP; Adanin VM; Ozerskaya SM; Gräfe U
Pharmazie; 2003 Jan; 58(1):76-7. PubMed ID: 12622263
[No Abstract] [Full Text] [Related]
11. Antibacterial secondary metabolites from an endophytic fungus, Eupenicillium sp. LG41.
Li G; Kusari S; Lamshöft M; Schüffler A; Laatsch H; Spiteller M
J Nat Prod; 2014 Nov; 77(11):2335-41. PubMed ID: 25356913
[TBL] [Abstract][Full Text] [Related]
12. Alteration of membrane polarization by (-)-terpestacin, a biologically active fungal metabolite.
Grigoriev PA; Schlegel B; Schmidtke M; Gräfe U
Pharmazie; 2002 Sep; 57(9):653-4. PubMed ID: 12369460
[No Abstract] [Full Text] [Related]
13. MK4588, a new antibiotic related to xanthocillin.
Itoh J; Takeuchi Y; Gomi S; Inouye S; Mikawa T; Yoshikawa N; Ohkishi H
J Antibiot (Tokyo); 1990 May; 43(5):456-61. PubMed ID: 2358397
[TBL] [Abstract][Full Text] [Related]
14. Cyclic 1,2-diketones as core building blocks: a strategy for the total synthesis of (-)-terpestacin.
Trost BM; Dong G; Vance JA
Chemistry; 2010 Jun; 16(21):6265-77. PubMed ID: 20411537
[TBL] [Abstract][Full Text] [Related]
15. Sch 38519, a novel platelet aggregation inhibitor produced by a Thermomonospora sp. Taxonomy, fermentation, isolation, physico-chemical properties, structure and biological properties.
Patel M; Hegde V; Horan A; Barrett T; Bishop R; King A; Marquez J; Hare R; Gullo V
J Antibiot (Tokyo); 1989 Jul; 42(7):1063-9. PubMed ID: 2753813
[TBL] [Abstract][Full Text] [Related]
16. Anguillosporal, a new antibacterial and antifungal metabolite from the freshwater fungus Anguillospora longissima.
Harrigan GG; Armentrout BL; Gloer JB; Shearer CA
J Nat Prod; 1995 Sep; 58(9):1467-9. PubMed ID: 7494152
[TBL] [Abstract][Full Text] [Related]
17. Fusaproliferin, Terpestacin and Their Derivatives Display Variable Allelopathic Activity Against Some Ascomycetous Fungi.
Cimmino A; Sarrocco S; Masi M; Diquattro S; Evidente M; Vannacci G; Evidente A
Chem Biodivers; 2016 Nov; 13(11):1593-1600. PubMed ID: 27448697
[TBL] [Abstract][Full Text] [Related]
18. Helioferins; novel antifungal lipopeptides from Mycogone rosea: screening, isolation, structures and biological properties.
Gräfe U; Ihn W; Ritzau M; Schade W; Stengel C; Schlegel B; Fleck WF; Künkel W; Härtl A; Gutsche W
J Antibiot (Tokyo); 1995 Feb; 48(2):126-33. PubMed ID: 7706122
[TBL] [Abstract][Full Text] [Related]
19. Roseoferin, a new aminolipopeptide antibiotic complex from Mycogone rosea DSM 12973, structures and biological activities.
Degenkolb T; Heinze S; Schlegel B; Dornberger K; Möllmann U; Dahse HM; Gräfe U
J Antibiot (Tokyo); 2000 Feb; 53(2):184-90. PubMed ID: 10805580
[No Abstract] [Full Text] [Related]
20. Total synthesis of (+/-)-terpestacin and (+/-)-11-epi-terpestacin.
Berger GO; Tius MA
J Org Chem; 2007 Aug; 72(17):6473-80. PubMed ID: 17630803
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
